Research.Patient.info
Localized Prostate Cancer research hub
2 indexed studies · 1 currently recruiting
- recruitingNA
The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance
This study looks at treating early prostate cancer with just 3 daily radiotherapy sessions instead of 5. It uses a special tracking system, like a GPS, to make sure the treatment is super accurate, aiming for fewer side effects and better comfort for patients. It's for men with early-stage prostate cancer.
United Kingdom - authorisedTherapeutic exploratory (Phase II)
Ultra-hypofractionated radiotHErapy and concomitant oral RelugOlix for treatment of intermediate risk prostate cancer. (Ultra-HERO)
This study looks at a new way to treat prostate cancer. It combines a special, shorter course of radiation therapy with a new oral medicine called relugolix. The aim is to see how well this treatment can lower a specific marker (PSA) in the blood for men with intermediate-risk prostate cancer.
Italy